Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
National Alliance for Sickle Cell Centers
Study ID
NCT06071377
Status
Recruiting

Conditions

  • Sickle Cell Trait

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Biologic Specimen Collection — OTHER
    Participants will have blood and urine collected at Baseline

Study Details

The main purpose of this study is to create a longitudinal cohort of those with Sickle Cell Trait (SCT) to better understand the hematologic phenotype for those that carry HbS, assess for differences in those with varying quantities of HbS and assess for potential clinical complications of SCT.

Key Dates

Start date
Apr 1, 2023
Status verified
Nov 2025
Primary completion
Dec 31, 2026
Completion
Feb 28, 2027

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Individuals with sickle cell trait

Primary Outcome Measure

Hemoglobin variant quantification [ Time Frame: Through study completion, an average of 2 years ]

Central Contacts

Locations (10)

FacilityCityStateZIPSite coordinators
University of AlabamaBirminghamAlabama35294
Marteesa William Oliver
Julie Kanter (PRINCIPAL_INVESTIGATOR)
Loma Linda University Health CareLoma LindaCalifornia92354
Monica Pizana
Akshat Jain (PRINCIPAL_INVESTIGATOR)
Nemours Children's HospitalWilmingtonDelaware19803
Nicole Wittmeyer
Robin Miller, MD (PRINCIPAL_INVESTIGATOR)
Indiana UniversityIndianapolisIndiana46202
Claire Kendrick
Andrew O'Brien (PRINCIPAL_INVESTIGATOR)
Functional FluidicsDetroitMichigan48202
Jennell White, PhD
Ifeoma Iwuagwu
Patrick Hines, MD (PRINCIPAL_INVESTIGATOR)
University of North CarolinaChapel HillNorth Carolina27599
David Wichlan
Patrick Ellison (PRINCIPAL_INVESTIGATOR)
Duke UniversityDurhamNorth Carolina27710
JJ Strouse, MD (PRINCIPAL_INVESTIGATOR)
East Carolina UniversityGreenvilleNorth Carolina27834
Beng Fuh (PRINCIPAL_INVESTIGATOR)
Nationwide Children's HospitalColumbusOhio43205
Tiffany Rosetti
Anthony Villella, MD (PRINCIPAL_INVESTIGATOR)
UT Health HoustonHoustonTexas77030
Amanda Gregg
Idowu Modupe, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Birmingham, AL

Related Studies